American Journal of Clinical Pathology · 2002 · 113 citations · 11 references
MedicineEndocrinologyOncologyBreast OncologyEndocrine OncologyHormone BiochemistryBreast PathologyEndocrine AssessmentEndocrine TestingEndocrine Tumor PathologyHormonal EvaluationImmunohistochemistryBreast Cancer Response AssessmentEstrogen Receptor ExpressionImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingInterlaboratory ReproducibilityInterobserver ReproducibilityTissue Microarray Analysis
Semiquantitative immunohistochemical assessment of estrogen receptor (ER) is used to predict the likelihood of response to antiestrogen therapy in breast carcinoma. If semiquantitative immunohistochemical analysis leads to therapeutic decisions, the importance of standardization and quality control increases. ER assessment reproducibility was studied among 172 laboratories using tissue microarray slides with 20 tissue spots negative and 10 tissue spots expressing ER at low, medium, or high levels. More than 80% of the laboratories demonstrated ER positivity in the medium- and high-expressing tissue spots, but only about 43% succeeded with tissue spots with low expression. Poor interlaboratory agreement was based on insufficient retrieval efficacy as shown by additional tests using autoclave pretreatment. The immunohistochemical scores used to quantify therapeutic target molecules remain inconclusive as long as progress toward standardized immunohistochemical procedures and evaluation is not achieved. Tissue microarray technology has proved its suitability for large-scale immunohistochemical trials, giving rise to new dimensions in control assessment.
11
The Measurement of Observer Agreement for Categorical Data
J. Richard Landis, Gary G. Koch · Biometrics · 1977 · 78.9K citations · Full text
Timothy W. Jacobs, Allen M. Gown, Hadi Yaziji et al. · Journal of Clinical Oncology · 1999 · 459 citations · Full text
Anthony Rhodes, Bharat Jasani, DM Barnes et al. · Journal of Clinical Pathology · 2000 · 332 citations · Full text
Medicine, Oncology, Breast Oncology +15